Morgan Stanley Biora Therapeutics, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	SELL	$0.13 - $12.03 $7,904 - $731,424	-60,800 Reduced 79.91%	15,281 $1,000
Q3 2022 Nov 14, 2022	SELL	$0.53 - $13.3 $28,772 - $722,030	-54,288 Reduced 41.64%	76,081 $37,000
Q2 2022 Oct 27, 2022	BUY	$0.56 - $1.22 $43,050 - $93,788	76,876 Added 143.71%	130,369 $91,000
Q2 2022 Aug 15, 2022	BUY	$0.56 - $1.22 $43,050 - $93,788	76,876 Added 143.71%	130,369 $91,000
Q1 2022 Oct 27, 2022	SELL	$1.11 - $2.25 $85,332 - $172,971	-76,876 Reduced 58.97%	53,493 $62,000
Q1 2022 May 13, 2022	SELL	$1.11 - $2.25 $3,930 - $7,967	-3,541 Reduced 6.21%	53,493 $62,000
Q4 2021 Feb 14, 2022	BUY	$1.35 - $4.89 $17,316 - $62,724	12,827 Added 29.02%	57,034 $120,000
Q3 2021 Nov 15, 2021	BUY	$0.67 - $3.41 $29,618 - $150,745	44,207 New	44,207 $68,000

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $105M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.